NAMI vs MAX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 21, 2026

NAMI

51.7
AI Score
VS
MAX Wins

MAX

57.0
AI Score

Investment Advisor Scores

NAMI

52score
Recommendation
HOLD

MAX

57score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NAMI MAX Winner
Revenue 59.06M 1.11B MAX
Net Income -13.49M 25.62M MAX
Net Margin -22.8% 2.3% MAX
Operating Income -14.91M 22.12M MAX
ROE -112.5% 615.9% MAX
ROA -49.1% 6.7% MAX
Total Assets 27.49M 383.83M MAX
Cash 9.19M 46.88M MAX
Current Ratio 1.53 1.18 NAMI
Free Cash Flow -3.63M 65.26M MAX

Relative Price Performance (Last 90 Days)

NAMI 1M: -20.2% · 3M: +596.6% MAX 1M: -5.1% · 3M: +40.1%

Current Technical Phase

NAMI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (147.8% over 20 days), RSI 52

RSI (14): 51.6 · Price: $2.76

MAX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.2 · Price: $12.75

Fundamentals Snapshot

Metric NAMI MAX
Market Cap
Forward P/E 0.0 8.2
Trailing P/E 7.6
Revenue (TTM)
Revenue Growth 0.0% 0.3%
Gross Margin 0.1% 0.1%
Operating Margin -0.4% 0.1%
EPS -4.66 1.62
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, MAX is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.